Myasthenia Gravis
Conference Recap
Myasthenia Gravis Highlights From AANEM 2024
Highlights in myasthenia gravis from AANEM 2024 include efficacy data on efgartigimod, ravulizumab, zilucoplan, and first-in-class inebilizumab,...
Conference Coverage
Myasthenia Gravis: Where Does Traditional Therapy Fit In?
Neurologists debate the data on familiar immunosuppressive agents.
Conference Coverage
Neurologists Lack Awareness of Steroid Toxicity
Over 85% of survey respondents indicated that a tool for systematically monitoring corticosteroid toxicity would be valuable.
Conference Coverage
Digital Tool May Help Neurologists Assess Steroid Toxicity
The study results “indicate that patients with MG who initiated steroids demonstrated evidence of steroid toxicity in as little as 90 days after...
Conference Coverage
Pediatric Myasthenia Gravis: Don’t Treat Children Like Adults
Conference Coverage
Myasthenia Gravis: Similar Symptoms in Relatives Raise Question of Genes
Conference Coverage
Sustained Control with Investigational Monoclonal Antibody for Myasthenia Gravis
The VIVACITY-MG3 trial is the first registrational study of a neonatal fragment crystallizable receptor blocker to show sustained efficacy through...
Conference Coverage
First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis
Although inebilizumab is already FDA-approved for the treatment of neuromyelitis optica, it still faces approval and indication hurdles for MG.
Rare Disease Report 2024
Myasthenia Gravis: Patient Choice, Cultural Change
Used appropriately, newer treatments for myasthenia gravis can provide dramatic results faster and more safely than broad immunosuppressants.
Roundtable
Game-Changing Therapies for Myasthenia Gravis
In this roundtable, Drs Henry Kaminski, Pushpa Narayanaswami, and Nicholas J. Silvestri examine the latest therapeutic options and how best to...
Conference Recap
Myasthenia Gravis Highlights From AAN 2024
Highlights in myasthenia gravis from AAN 2024 include the LUMINESCE, ADAPT NXT, CHAMPION MG trials and a look at the effectiveness of early...